Recently, our group has hypothesized that PSGL-1 may potentially be utilized as a biomarker for pathological conditions such as immunological status, inflammation/translocation, cell exhaustion, and cancers in HIV infection (91). Here, SELPLG is linked to HIV infectious disease.